Fri, June 4, 2021
Thu, June 3, 2021
Wed, June 2, 2021
Tue, June 1, 2021
Fri, May 28, 2021
Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021
Mon, May 24, 2021

David Lebowitz Maintained (ASND) at Buy with Increased Target to $201 on, May 28th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-201-on-may-28th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $199 to $201 on, May 28th, 2021.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, March 30th, 2021


This is the rating of the analyst that currently disagrees with David


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 12th, 2021

Publication Contributing Sources